Evolv Technologies Holdings Future Growth
Future criteria checks 1/6
Evolv Technologies Holdings is forecast to grow earnings and revenue by 1.5% and 15.5% per annum respectively while EPS is expected to grow by 3% per annum.
Key information
1.5%
Earnings growth rate
3.02%
EPS growth rate
| Electronic earnings growth | 25.2% |
| Revenue growth rate | 15.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 14 May 2026 |
Recent future growth updates
Recent updates
Narrative Update • May 02
EVLV: Raised 2026 Guidance And Venue Wins Will Support Future Upside
Analysts have raised their fair value estimate for Evolv Technologies Holdings from $9.50 to $10.00, citing updated assumptions around discount rates, revenue growth, profit margins, and a higher future P/E multiple as key drivers of the new price target. What's in the News Evolv raised its 2026 revenue guidance to a range of US$172 million to US$178 million, compared with prior guidance of US$160 million to US$165 million, following an Analyst and Investor Day focused on vision, strategy, growth initiatives, products, technology and financial goals.
Narrative Update • Apr 18
EVLV: Stadium And Hospital Security Contracts Will Drive Multi Year Upside
Analysts have adjusted their price target on Evolv Technologies Holdings to $10.50. The change reflects updated assumptions around discount rate, revenue growth, profit margin and future P/E, rather than a shift in fair value.
Narrative Update • Apr 03
EVLV: Expanding Stadium And Hospital Contracts Will Drive Long Term Upside
Analysts have modestly adjusted their price target on Evolv Technologies Holdings, keeping fair value at $9.50 while fine tuning assumptions around the discount rate, revenue growth, profit margin, and future P/E to reflect updated views on the company’s risk profile and long term earnings potential. What's in the News Evolv renewed and expanded its subscription agreement with the Houston Astros, upgrading the venue wide deployment at 41,000 seat Daikin Park to Express Gen2 hardware and adding eXpedite bag screening for staff, which brings Evolv’s professional baseball customer count to twelve.Narrative Update • Mar 20
EVLV: Expanded Stadium And Hospital Contracts Will Support Multi Year Upside
Analysts have nudged their price target for Evolv Technologies Holdings up from $10.00 to $10.50. They point to updated assumptions around slightly higher revenue growth, a marginally lower discount rate, and a modestly lower future P/E as key drivers of the change.Narrative Update • Mar 06
EVLV: Expanding Stadium And Healthcare Contracts Will Support Bullish Multi Year Upside
Analysts have adjusted their price target on Evolv Technologies Holdings to $10.00, with the change linked to updated assumptions around revenue growth, profit margins and the future P/E multiple, even though the headline fair value figure remains stated at $10.00. What's in the News Evolv extended and expanded its multi year hardware and software subscription with Bank of America Stadium in Charlotte, upgrading nearly twenty Evolv Express systems to Gen2 hardware and adding eXpedite bag screening ahead of the March 7, 2026 Charlotte FC home opener (Client announcement).Narrative Update • Feb 20
EVLV: Venue Partnerships Will Set Up A Breakout Year In 2026
Analysts have adjusted their price targets for Evolv Technologies Holdings slightly, reflecting updated assumptions around discount rates, revenue growth of about 17.85%, profit margins near 8.19%, and a future P/E of roughly 139.15x. These inputs support a refined view of fair value that remains around $9.50 per share.Narrative Update • Feb 05
EVLV: Q3 Outperformance And 2026 ARR Focus Will Support Bullish Case
Analysts lifted their price target on Evolv Technologies Holdings to US$10 from US$9, citing recent quarterly performance and expectations that annual recurring revenue growth could outpace revenue growth by 2026. Analyst Commentary Recent commentary from bullish analysts centers on a higher conviction view of Evolv Technologies Holdings after its latest quarterly report, with particular attention on the relationship between annual recurring revenue and total revenue over the medium term.Narrative Update • Jan 22
EVLV: ARR Momentum Will Set Up A Breakout Year In 2026
Narrative Update on Evolv Technologies Holdings Analysts have raised their price target on Evolv Technologies Holdings to $10 from $9, citing a recent quarterly performance described as a strong beat and noting expectations that by 2026 annual recurring revenue growth could exceed reported revenue growth. Analyst Commentary The latest price target change to US$10 highlights that some on the Street see upside potential, but even supportive research comes with clear caveats around how the story could play out over the next few years.Narrative Update • Jan 08
EVLV: Q3 Beat And 2026 ARR Breakout Potential Support Bullish Outlook
Analysts have raised their fair value estimate for Evolv Technologies Holdings to $10.00 from $8.25 after a Q3 performance that they describe as very strong, and based on expectations that annual recurring revenue growth could outpace overall revenue growth by 2026. Analyst Commentary Bullish analysts are pointing to Evolv Technologies Holdings' Q3 performance as a key support for higher valuation expectations, with recent fair value and price target increases signaling growing confidence in the company’s execution.Narrative Update • Dec 14
EVLV: ARR Momentum Will Drive A Breakout Year In 2026
Analysts lifted their price target on Evolv Technologies Holdings by $1 to $10, citing a substantial Q3 beat and expectations that accelerating ARR growth will position 2026 as a breakout year. Analyst Commentary While the latest price target increase to $10 reflects optimism around Evolv Technologies Holdings' Q3 performance and medium term growth prospects, not all market observers are uniformly bullish.Narrative Update • Aug 16
Multi-Year Contracts With Public Schools And Hospitals Will Expand Markets
The analyst price target for Evolv Technologies Holdings has been raised significantly, driven by a Q2 earnings beat, upgraded FY25 revenue guidance, improved business outlook following regulatory clarity and management changes, as well as momentum across key industry verticals, lifting the consensus fair value from $7.19 to $9.50. Analyst Commentary Q2 earnings beat on both revenue and AEBITDA, leading to upgraded financial forecasts for FY25.New Narrative • Jun 01
AI Screening Will Expand Public Safety Applications
Heightened demand for advanced security and regulatory mandates drive strong growth potential for recurring subscription revenue across diverse markets.Analysis Article • May 21
The Price Is Right For Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Even After Diving 28%
Unfortunately for some shareholders, the Evolv Technologies Holdings, Inc. ( NASDAQ:EVLV ) share price has dived 28% in...Analysis Article • Feb 16
After Leaping 29% Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Shares Are Not Flying Under The Radar
The Evolv Technologies Holdings, Inc. ( NASDAQ:EVLV ) share price has done very well over the last month, posting an...Analysis Article • Jan 23
Here's Why We're Not At All Concerned With Evolv Technologies Holdings' (NASDAQ:EVLV) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, although...Analysis Article • Dec 14
After Leaping 33% Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Shares Are Not Flying Under The Radar
Evolv Technologies Holdings, Inc. ( NASDAQ:EVLV ) shareholders are no doubt pleased to see that the share price has...Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 209 | -36 | N/A | 30 | 4 |
| 12/31/2026 | 177 | -36 | N/A | 23 | 4 |
| 3/31/2026 | 160 | -36 | -10 | 18 | N/A |
| 12/31/2025 | 146 | -33 | -18 | 19 | N/A |
| 9/30/2025 | 137 | -60 | -35 | 6 | N/A |
| 6/30/2025 | 121 | -88 | -25 | 6 | N/A |
| 3/31/2025 | 114 | -44 | -47 | -17 | N/A |
| 12/31/2024 | 104 | -54 | -68 | -31 | N/A |
| 9/30/2024 | 95 | -55 | -85 | -37 | N/A |
| 6/30/2024 | 89 | -21 | -101 | -39 | N/A |
| 3/31/2024 | 83 | -91 | -102 | -23 | N/A |
| 12/31/2023 | 80 | -108 | -82 | -10 | N/A |
| 9/30/2023 | 77 | -120 | -71 | -12 | N/A |
| 6/30/2023 | 76 | -142 | -77 | -31 | N/A |
| 3/31/2023 | 65 | -101 | -80 | -49 | N/A |
| 12/31/2022 | 53 | -87 | -99 | -75 | N/A |
| 9/30/2022 | 41 | -53 | -110 | -84 | N/A |
| 6/30/2022 | 33 | -14 | -113 | -91 | N/A |
| 3/31/2022 | 28 | -11 | -97 | -74 | N/A |
| 12/31/2021 | 23 | -11 | -74 | -57 | N/A |
| 9/30/2021 | 19 | -25 | -61 | -47 | N/A |
| 6/30/2021 | 12 | -52 | -41 | -28 | N/A |
| 3/31/2021 | 8 | -35 | -36 | -27 | N/A |
| 12/31/2020 | 5 | -27 | -30 | -23 | N/A |
| 12/31/2019 | 6 | -20 | N/A | -15 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EVLV is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: EVLV is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: EVLV is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: EVLV's revenue (15.5% per year) is forecast to grow faster than the US market (11.7% per year).
High Growth Revenue: EVLV's revenue (15.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EVLV's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/18 08:42 |
| End of Day Share Price | 2026/05/15 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Evolv Technologies Holdings, Inc. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jeremy Hamblin | Craig-Hallum Capital Group LLC |
| Eric Martinuzzi | Lake Street Capital Markets, LLC |
| Michael Latimore | Northland Capital Markets |